STUDY QUESTION: Does publication bias or non-publication exist in fertility trials presented as conference abstracts?
Introduction
Randomized controlled trials (RCTs) are considered the most robust method to assess the effect of a proposed treatment for a specific health problem. Systematic reviews aggregate the results from multiple RCTs, evaluate the quality of the research, and provide a summary of the utility of the intervention. These reviews are therefore considered the highest standard of resource for evidence based healthcare. However, the very premise of a systematic review is undermined if it fails to include all relevant existing evidence. This can occur when the results from an individual trial are not available because they have not been published, or have been reported incompletely, for example in the form of a conference abstract. Failure to publish the outcomes of trials results in non-publication or publication deficit (Evers, 2000) . Non-publication is also a publication bias if there is 'any tendency on the parts of the investigators or editors to fail to publish study results on the basis or strength of the study findings' (Dickersin and Min, 1993) . Many studies have reported that trials with statistically significant results are more likely to reach full-text publication than trials with negative or null results (Scherer et al., 2007; Hopewell et al., 2009; Song et al., 2010) . Publication bias can result in a misleading and inaccurate interpretation about the direction or strength of an intervention's effect in a systematic review (Hopewell et al., 2009) . As these reviews are used to inform clinical practice and to develop health policy and guidelines, non-publication and publication bias ultimately impact on patient care.
For the past decade there has been a growing focus on improving the quality and reporting of RCTs, and the systematic reviews that follow (Moher et al., 2009 (Moher et al., , 2010 Whiting et al., 2016) . Trial registration was introduced in 2005 by the World Health Organization (WHO) in efforts to improve transparency and monitoring of non-publication, and highlight the importance of this issue (De Angelis et al., 2004) . Despite this, a recent study reports that only 44% of trials in the field of fertility research have been registered (Farquhar et al., 2017) .
A common way to investigate the presence of non-publication and publication bias is to evaluate the full-text publication rate of studies presented at conferences, which are often available as short conference abstracts (Scherer et al., 2007) . Publication bias has been inconsistently detected in the area of fertility research, however, this has only been studied among abstracts from a single scientific conference (Evers, 2000; Polyzos et al., 2011) . Further, the most recent cohort examined is now over a decade old, and re-appraisal of this phenomenon is overdue. Fertility research is a dynamic area, and novel interventions are constantly being developed and tested. Examples from recent years include endometrial scratching, time-lapse imaging of embryos and intravaginal embryo culture (Armstrong et al., 2015; Nastri et al., 2015; Doody et al., 2016) .
Given the growing number of trials and systematic reviews in this area, and increased awareness of the issue of non-publication, the aim of this study was to determine if non-publication and publication bias exist in a recent cohort of RCTs presented at fertility conferences.
Methods

Trial identification
The Cochrane Gynaecology and Fertility Database was searched for conference abstracts of RCTs published between 01/01/2007 and 31/12/ 2010 (Supplementary Data). This database was established in 1996 and includes RCTs of gynaecology and fertility trials. It is updated from weekly searches of MEDLINE, Embase, CINAHL, PsycINFO and hand searching of relevant conference proceedings.
Eligible studies were RCTs investigating a fertility intervention and reporting results on at least one reproductive outcome (e.g. pregnancy, implantation rate, fertilization rate or embryo, oocyte or sperm quality). Studies reporting only endocrine or biochemical outcomes were excluded. Studies described as equivalence or non-inferiority design were excluded, as a positive outcome in this context is normally that of no difference between a new treatment and an existing regime. Two authors independently screened abstracts for inclusion and performed data extraction. Any discrepancies were resolved by a third author. Multiple abstracts on the same study were combined and information from all was used as required. The registration status of the trials was determined by searching clinicaltrials.gov and the WHO International Clinical Trials Registry Platform.
Publication bias was defined as an increased probability of full-text publication among conference abstracts reporting positive results, compared to conference abstracts presenting negative or null results. The results of each abstract was categorized as 'positive' or 'non-positive' based on three different scenarios as described previously (Polyzos et al., 2011) , with a positive result occurring in the instance of:
(1) A statistically significant result for at least one reproductive outcome. (2) A statistically significant result for at least one reproductive outcome, which favoured the intervention arm/novel treatment. (3) A positive overall conclusion: either a statistically significant effect for at least one reproductive outcome, or a positive statement made about the results (e.g. describing a trend towards a beneficial effect).
Non-publication was defined as the proportion of conference abstracts reaching/not reaching full-text publication within the follow-up period of this study. Time to publication was defined as the number of months between conference abstract presentation and full-text publication, and was calculated using time-to-event analysis to account for the abstracts which did not reach full-text publication within the follow-up period.
In addition, the following information from the abstract was recorded: the type of presentation (oral or poster), month and year of presentation (January 2007 -December 2010 , geographical location of the lead author (country), funding source (industry or non-industry), stage of study (interim or complete), registration status (registered prospectively, retrospectively or not registered) and convening society of the conference (e.g. ESHRE and ASRM).
Full-text searching
One author searched the following databases to identify published fulltext reports of the included abstracts using relevant keywords and the names of the first, last and corresponding abstract authors: Cochrane Gynaecology and Fertility Database, PubMed, MEDLINE, Embase, CINAHL and Google, (last searched May 2015). A probabilistic approach was used to identify and match full-text publications to the abstract, including trial registry numbers, at least one of the same authors, identical or very similar titles, methodology, recruitment period, number of patients recruited, and trial results. If not identified by one author, a second author searched for the full-text publication. When no full-text could be identified, one or more abstract authors were sent an email querying the publication status of the study. If no response was received a second email was sent 2-4 weeks later.
Most subsequently published abstracts are published within 4 years (Scherer et al., 2007) . The selected timeframe provided a reasonable sample size of the most recent cohort (2007) (2008) (2009) (2010) , while allowing sufficient time for full-text publication (full-text searches conducted May 2015).
Statistical analyses
Chi-square tests were performed to investigate the effects of different variables on the probability of full-text publication. Odds ratios were calculated for each variable, and multivariable odds ratios were calculated using logistic regression adjusting for the variables: type of presentation, year of presentation, geographical location of the lead author, funding source, stage of study, registration status, convening society of the conference, and the third test of 'positive' (overall conclusion positive). Hazard ratios were calculated to test the association between variables and time to publication using Cox regression. Multivariate Cox regression also included the variables listed above. Time to publication was calculated as the number of months between the conference and the date the article was first published as fulltext, including online publication. Where multiple abstracts of the same study were included, the date of the earliest abstract was used for time to event analysis. Any abstracts which were not published before May 2015 were censored in the analysis. Trials which were published as full-text articles prior to abstract presentation, and were therefore never exposed to a potential of non-publication, were removed from this analysis. Where percentages were calculated, results were presented with 95% confidence intervals. Where medians were calculated, results were presented with corresponding interquartile range (IQR). The level of statistical significance was set at 0.05 for all analyses. Statistical analysis was performed using STATA (Version 14.1, College Station, TX: StataCorp LP) and OpenEpi (Sullivan et al., 2009; StataCorp, 2015) . Ethics approval was not sought for this study.
Results
Abstract characteristics
Of the 337 articles retrieved from the initial search, 113 did not meet the eligibility criteria and were excluded leaving a total of 224 abstracts (Fig. 1) . The majority of included abstracts were presented at the two major fertility conferences: the Annual Meeting of the American Society of Reproductive Medicine (ASRM) (101, 45%; 95% CI: 39, 52) and the Annual Meeting of the European Society for Human Reproduction and Embryology (ESHRE) (111, 50%; 95% CI: 43, 56). Most abstracts were poster presentations from European researchers (Table I) . It was not possible to calculate a median time to publication using survival analysis as less than 50% of studies in this cohort reached full-text publication. Of the abstracts reaching full-text publication, the median time to publication was 17.5 months (IQR: 6.3, 31.3).
Non-publication
Full-text searching identified 106 of the abstracts as being published, and emails to authors resulted in the identification of a further four full-text papers, giving a total of 110 full-text papers. The overall publication rate was 49% (95% CI: 43, 56) (Fig. 1) . Full-text articles were most frequently published in Fertility and Sterility (36, 33%; 95% CI: 25, 42), Human Reproduction (18, 16%; 95% CI: 10, 24), and Reproductive BioMedicine Online (16, 15%; 95% CI: 9, 22).
Publication bias
This study did not identify any publication bias: there was no statistically significant difference between the probabilities of full-text publication of abstracts reporting positive results compared to those reporting negative or null results (Table I ). This result held across the three scenarios of positive results tested, and was not altered by multivariable analysis. There was no difference in time to publication between positive and non-positive abstracts across all three scenarios examined (Table I) .
Secondary study characteristics
Of all the secondary characteristics investigated, the abstracts which were presented as oral presentations, at the ESHRE meeting, by Middle-Eastern authors, and which were registered, were more likely to reach full-text publication (Table I) . Similarly, time to publication was shorter in these cases. After multivariable analysis only oral presentations and registered abstracts were associated with a higher probability of full-text publication, and faster time to publication (Figs 2 and 3). Year of publication remained a significant factor influencing probability of publication, but not time to publication (Table I) .
Discussion
Summary of findings
Publication bias
Only half of the fertility RCTs presented at conferences between 2007 and 2010 have been published as full-text journal articles, 4 or more years after their conference presentation. While this study reports a high level of non-publication, it did not identify any publication bias. Two cohort studies of RCTs in the area of reproductive medicine have yielded conflicting results about publication bias (Evers, 2000; Polyzos et al., 2011) . Only the most recent study identified publication bias, however this was only detected when the positive result was a statistically significance result in favour of the intervention arm. Our larger study of a more recent cohort of trial abstracts from multiple fertility conferences, did not identify publication bias using this definition. Furthermore, time to publication was not significantly different between studies with and without positive results in this cohort. The absence of publication bias in this study is promising, and may reflect a shift towards increased focus on research methodology rather than research results, among journal editors and researchers alike.
Secondary trial characteristics
Oral abstract presentations were more likely to be published, and published earlier, than poster presentations, a finding which has been previously reported (Scherer et al., 2007) . This could be explained by the observation that oral presentations are often of a higher quality or topic of interest than poster presentations, and may therefore be more likely to both warrant the researchers' time in preparing a manuscript and to be accepted by journal editors.
The publication rate differed by country in this cohort, for example studies from the Middle-East had a publication rate of 65% (95% CI: 49, 79) compared to only 26% (95% CI: 13, 42) of studies from Asia, however this effect was not significant after multivariable analysis. Previous reports have not identified any association between the country or native language of the researchers and the chance of fulltext publication (Scherer et al., 2007) .
It appears that the abstracts presented a longer time ago are more likely to have reached full-text publication than those presented more recently, for example 64% (95% CI: 48, 78) of abstracts presented in 2008 and only 37% (95% CI: 27, 48) of those presented in 2010, have been published. Although previous studies have suggested that most papers are published within the first four years following presentation (Scherer et al., 2007) , it may be that this study did not allow enough time for the presentation of papers presented in 2010. Other studies investigating time to publication of fertility abstracts have reported median times to publication of 32.5 months, and a Cochrane review across a broad range of medical areas reports a median time to publication of 17.9 months (Scherer et al., 2007) . 
Continued
Trial registration was introduced in 2005 as a step towards increased transparency around the conduct of clinical trials on humans, and as a means of detecting unpublished studies. In this cohort, abstracts which were registered were more likely to be published than those which were not. However, trial registration itself does not ensure clinical trial publication and this study found only 83% (95% CI: 71, 91) of registered studies were subsequently published. Further, 40% (95% CI: 28, 54) of the registered abstracts in this cohort were registered retrospectively, after their presentation at the conference.
It is likely that these studies were registered only to fulfil this criterion at the time of submitting their paper for publication. Members of the International Committee of Medical Journal Editors have agreed to consider only accepting prospectively registered trials for publication, although many unregistered or retrospectively registered trials continue to be published by many journals (Scott et al., 2015; Farquhar et al., 2017) . Paradoxically, this position may contribute to nonpublication or publication delay, as unregistered trials become more difficult to publish. Owing to the clear ethical obligations to publish clinical trial results, the WHO has recently released a statement detailing new requirements to both publish the results of trials in peer-reviewed journals and publish key results alongside the trial registration page, within 12 months of trial closure (Moorthy et al., 2015) .
Non-publication
Less than half of the fertility trial abstracts in this study reached full-text publication (49% CI: 42.6, 55.6). These findings are similar to previous reports. A review including 79 studies of abstract cohorts across multiple disciplines reported the probability of an RCT being published after nine years as 63% (Scherer et al., 2007) . The publication rate of fertility trials does not seem to have improved in the last 20 years, with publication rates of 56 and 57% reported in conference abstracts presented in 1992-1997 (Evers, 2000 ), and 2003 -2004 (Polyzos et al., 2011 , respectively.
Failure to publish research results, especially research on humans, is a scientific, ethical and moral misconduct (Dickersin and Min, 1993) . Many participants in trials take part altruistically, believing that their involvement will contribute to further knowledge and help others in similar positions to themselves (Jenkins and Fallowfield, 2000) . Although non-publication does not itself skew review outcomes in theory, it reduces the power of a meta-analysis to detect a significant effect if one exists. Therefore, failure to publish is a serious problem for the scientific and clinical community who depend on the results of trials to make clinical and research decisions, and to inform the production of guidelines at national and international levels. Failure to publish contributes to research waste and may result in duplication of effort, addressing questions that have already been investigated, but not published (Fergusson et al., 2005) . Ultimately, non-publication harms patients. Previous research investigating reasons for nonpublication have pointed to a role of authors' lack of time, resources or motivation to publish and journal editors' preference to publish more interesting results (Scherer et al., 2015) . A more comprehensive investigation into the reasons or causes of non-publication may assist in the development of mechanisms to facilitate the publication of research in the future, especially RCTs. Open access journals provide one avenue, however, there is normally a cost which may be prohibitive for some research groups. However, any expedited publication pathways for researchers reporting on RCTs would need to have proper checks in place to safe-guard the quality of research.
The cohort from this study was derived from conference abstracts which are often published in abstract booklets, and as such some study data is available for inclusion in systematic reviews and meta-analysis. However, these abstracts are only available to those with access to the conference proceedings, and often need to be hand-searched due to time-lag between the conference and subsequent indexing of abstracts in major databases. Further, not all critical aspects of the trial design, methodology, and results, can be reported in a short abstract. Therefore, the full-text report of trials is required for access to the complete study results, and to enable comprehensive peer review and assessment of potential bias. Further, the content of an abstract and subsequent full-text has been shown to differ significantly in some cases and controversy remains regarding whether this grey literature should be included in Cochrane reviews and meta-analysis (Cook et al., 1993; McAuley et al., 2000; Song et al., 2010) . Although clarification of additional information can sometimes be obtained during the systematic review process from correspondence with trial authors, this approach is often unsuccessful, time consuming, and potentially unreliable (Wolfe et al., 2013) . The results reported here reaffirm the importance of hand-searching conference proceedings to ensure a comprehensive literature search, as the risk of excluding relevant information is substantial. 
Strengths and limitations
This study builds on the literature regarding non-publication in the fertility area, including 224 abstracts presented across a 4-year span with a minimum of 4 years follow-up. Additionally, this cohort included abstracts presented at more than one meeting as captured by the Cochrane Gynaecology and Fertility Database.
However, the use of conference abstracts to establish a cohort is unlikely to capture the true extent of non-publication and publication bias, as many trials are never presented as conference abstracts, and the same reasons and motivations that prevent full-text publication of abstracts are also likely to operate to prevent the presentation of trials at conferences. Currently it remains difficult to establish the true number of RCTs being conducted. The most comprehensive cohort of trials may come from ethics committee registers, although searching these registers from individual institutions would be logistically difficult. It also remains a possibility that the full-text search did not identify all published papers.
Conclusion
This study did not identify any publication bias, which may provide the fertility community with some reassurance regarding publication rates among trials with positive and negative or null results. However, only half of RCT abstracts presented at fertility conferences in Europe and America, have been published as full-text articles 4 or more years after their conference presentation. This is despite increasing awareness of the importance of publishing trial results, subsequent requirements for all RCTs to be registered prior to trial initiation, and more recently to be published within 12 months of trial closure.
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